← FDA Drug Approvals (Drugs@FDA)
SAPHNELO
BLA · Biologics License Application · Sponsor: ASTRAZENECA AB · Approved 2021-07-30
Drug application
- FDA Application #
BLA761123- Application type
- Biologics License Application
- Brand name
- SAPHNELO
- Generic name
- ANIFROLUMAB-FNIA
- Active ingredients
- ANIFROLUMAB-FNIA
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- ASTRAZENECA AB
- Manufacturer
- AstraZeneca Pharmaceuticals LP
- First approval
- 2021-07-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown